These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 22507770)

  • 41. Dyskeratosis congenita.
    Vulliamy T; Dokal I
    Semin Hematol; 2006 Jul; 43(3):157-66. PubMed ID: 16822458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
    Marrone A; Sokhal P; Walne A; Beswick R; Kirwan M; Killick S; Williams M; Marsh J; Vulliamy T; Dokal I
    Haematologica; 2007 Aug; 92(8):1013-20. PubMed ID: 17640862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Telomere dysfunction and tumor suppression responses in dyskeratosis congenita: balancing cancer and tissue renewal impairment.
    Hartwig FP; Collares T
    Ageing Res Rev; 2013 Mar; 12(2):642-52. PubMed ID: 23541441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations.
    Calado RT; Regal JA; Kajigaya S; Young NS
    Eur J Clin Invest; 2009 Nov; 39(11):1025-32. PubMed ID: 19674077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
    Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
    Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short telomeres in pulmonary fibrosis: from genetics to clinical significance.
    Trăilă D; Mlădinescu OF; Oancea C; Tudorache V
    Pneumologia; 2015; 64(1):8, 11-3. PubMed ID: 26016050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts.
    Westin ER; Chavez E; Lee KM; Gourronc FA; Riley S; Lansdorp PM; Goldman FD; Klingelhutz AJ
    Aging Cell; 2007 Jun; 6(3):383-94. PubMed ID: 17381549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dyskeratosis congenita.
    Dokal I
    Hematology Am Soc Hematol Educ Program; 2011; 2011():480-6. PubMed ID: 22160078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of telomere biology in bone marrow failure and other disorders.
    Savage SA; Alter BP
    Mech Ageing Dev; 2008; 129(1-2):35-47. PubMed ID: 18160098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human diseases of telomerase dysfunction: insights into tissue aging.
    Garcia CK; Wright WE; Shay JW
    Nucleic Acids Res; 2007; 35(22):7406-16. PubMed ID: 17913752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HuR regulates telomerase activity through TERC methylation.
    Tang H; Wang H; Cheng X; Fan X; Yang F; Zhang M; Chen Y; Tian Y; Liu C; Shao D; Jiang B; Dou Y; Cong Y; Xing J; Zhang X; Yi X; Songyang Z; Ma W; Zhao Y; Wang X; Ma J; Gorospe M; Ju Z; Wang W
    Nat Commun; 2018 Jun; 9(1):2213. PubMed ID: 29880812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The molecular genetics of the telomere biology disorders.
    Bertuch AA
    RNA Biol; 2016 Aug; 13(8):696-706. PubMed ID: 26400640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The wide-ranging clinical implications of the short telomere syndromes.
    Barbaro PM; Ziegler DS; Reddel RR
    Intern Med J; 2016 Apr; 46(4):393-403. PubMed ID: 26247919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
    Fogarty PF; Yamaguchi H; Wiestner A; Baerlocher GM; Sloand E; Zeng WS; Read EJ; Lansdorp PM; Young NS
    Lancet; 2003 Nov; 362(9396):1628-30. PubMed ID: 14630445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia.
    Bär C; Povedano JM; Serrano R; Benitez-Buelga C; Popkes M; Formentini I; Bobadilla M; Bosch F; Blasco MA
    Blood; 2016 Apr; 127(14):1770-9. PubMed ID: 26903545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice.
    Gu BW; Bessler M; Mason PJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10173-8. PubMed ID: 18626023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1.
    Guo Y; Kartawinata M; Li J; Pickett HA; Teo J; Kilo T; Barbaro PM; Keating B; Chen Y; Tian L; Al-Odaib A; Reddel RR; Christodoulou J; Xu X; Hakonarson H; Bryan TM
    Blood; 2014 Oct; 124(18):2767-74. PubMed ID: 25205116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Dyskeratosis congenita: short telomeres are not the rule].
    Touzot F; Le Guen T; de Villartay JP; Revy P
    Med Sci (Paris); 2012; 28(6-7):618-24. PubMed ID: 22805138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telomerase RNA levels limit the telomere length equilibrium.
    Greider CW
    Cold Spring Harb Symp Quant Biol; 2006; 71():225-9. PubMed ID: 17381301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.